Sartorius AG

SRT3

DE0007165631

Advanced Medical Equipment & Technology

Real-time Estimate Tradegate Other stock markets 11:08:17 2025-12-05 EST			5-day change	1st Jan Change
253.55 ^EUR	-1.46%		+0.76%	+17.61%

12-02	Sartorius Reduces Stake in Bico, Falls Below 5 Percent Voting Threshold	FW
11-13	Merck KGaA Shares Surge After Quarterly Results	DP

SARTORIUS VORZUEGE : Jefferies sticks Neutral

Published on 10/22/2024 at 02:05 pm EDT - Modified on 10/22/2024 at 02:52 pm EDT

MarketScreener with dpa-AFX Analyser

Sartorius AG

-1.46%

In his latest research note, analyst James Vane-Tempest confirms his recommendation. The broker Jefferies is keeping its Neutral rating. The target price continues to be set at EUR 243.

Latest news about Sartorius AG

12-02	Sartorius Reduces Stake in Bico, Falls Below 5 Percent Voting Threshold	FW
11-13	Merck KGaA Shares Surge After Quarterly Results	DP
11-04	ImpactFull Weekly - Asian CDMOs boom
10-29	Bio-Rad Q3 profit beats estimates helped by cost management	RE
10-22	SARTORIUS : Strong Q3 profitability drives guidance upgrade
10-22	SARTORIUS VORZUEGE : RBC reiterates its Buy rating	ZD
10-22	RBC raises target for Sartorius to €260 – 'Outperform'	DP
10-21	SARTORIUS VORZUEGE : Buy rating from Jefferies	ZD
10-21	Jefferies raises target for Sartorius to €275 - 'Buy'	DP
10-20	SARTORIUS VORZUEGE : Goldman Sachs remains Neutral	ZD
10-20	Goldman Raises Sartorius Price Target to 266 Euros, Maintains 'Neutral' Rating	DP
10-20	Mwb Keeps Sartorius at Sell Amid 'Limited' Earnings Catalysts	MT
10-17	SARTORIUS VORZUEGE : Deutsche Bank reaffirms its Buy rating	ZD
10-17	Deutsche Bank Raises Sartorius Target Price to 285 Euros - 'Buy' Rating Maintained	DP
10-17	Sartorius Shares Continue to Climb Amid Business Recovery	DP
10-17	SARTORIUS VORZUEGE : JP Morgan keeps its Buy rating	ZD
10-16	French stocks jump to seven-month high after government survives confidence vote	RE
10-16	Germany's DAX Index Ticks Up; Sartorius Climbs on Outlook Upgrade	MT
10-16	Sartorius Stedim Biotech: finally, are its troubles ending?
10-16	Sartorius Aktiengesellschaft, Sartorius Stedim Biotech S.A., Nine Months 2025 Earnings Call, Oct 16, 2025
10-17	After a good quarter: Sartorius becomes slightly more optimistic – share price rises	DP
10-16	SARTORIUS VORZUEGE : Jefferies reiterates its Buy rating	ZD
10-16	SARTORIUS VORZUEGE : RBC reaffirms its Buy rating	ZD
10-16	RBC Maintains 'Outperform' Rating for Sartorius with EUR250 Target	DP
10-16	Sartorius Aktiengesellschaft Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI

Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.

Employees

13,878

Sector

Advanced Medical Equipment & Technology

Calendar

01-21 - Q4 2025 Earnings Release (Projected)

More about the company